Celltrion
068270.KS
#651
Rank
โ‚น3.343 T
Marketcap
โ‚น14,697
Share price
-0.93%
Change (1 day)
28.96%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): โ‚น299.71

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น301.77. In 2025 the company made an earnings per share (EPS) of โ‚น286.52 an increase over its 2024 EPS that were of โ‚น108.67.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น299.714.61%
2025โ‚น286.52163.66%
2024โ‚น108.67-53.73%
2023โ‚น234.87-2.08%
2022โ‚น239.85-11.72%
2021โ‚น271.692.03%
2020โ‚น266.2882.8%
2019โ‚น145.6618.31%
2018โ‚น123.12-36.33%
2017โ‚น193.39161.25%
2016โ‚น74.022.86%
2015โ‚น71.9717.84%
2014โ‚น61.075.87%
2013โ‚น57.68-70.85%
2012โ‚น197.89134.09%
2011โ‚น84.5343.59%
2010โ‚น58.8774.49%
2009โ‚น33.74317.8%
2008โ‚น8.08-71.7%
2007โ‚น28.53